Re: Possibility?
|
4
|
Resverlogix Corp.
|
May 08, 2024 01:50PM
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Aug 01, 2024 03:56PM
|
Re: Random thoughts in the vacuum of information
|
5
|
Resverlogix Corp.
|
Jul 03, 2024 03:20PM
|
Re: Random thoughts in the vacuum of information
|
2
|
Resverlogix Corp.
|
Jul 03, 2024 03:36PM
|
Re: Recent publications:
|
6
|
Resverlogix Corp.
|
Sep 27, 2023 02:25PM
|
Re: Report Of Exempt Distribution.
|
4
|
Zenith Epigenetics
|
Apr 17, 2024 03:58PM
|
Re: Report Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Apr 17, 2024 07:10PM
|
Re: Reports of Exempt Distribution
|
1
|
Zenith Epigenetics
|
Feb 23, 2023 02:56PM
|
Re: Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes
|
8
|
Resverlogix Corp.
|
Aug 29, 2023 11:13AM
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
2
|
Resverlogix Corp.
|
Jun 13, 2023 12:32PM
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
1
|
Resverlogix Corp.
|
Oct 04, 2023 01:27PM
|
Re: RVX Price has nearly doubled in the past two days ...
|
4
|
Resverlogix Corp.
|
Feb 02, 2023 07:40PM
|
Re: Sent this to IR
|
5
|
Resverlogix Corp.
|
Nov 16, 2023 04:52PM
|
Re: Sept 30 2022 - Resverlogix streaming video
|
5
|
Resverlogix Corp.
|
Sep 30, 2022 12:48PM
|
Re: Share Price Today
|
3
|
Resverlogix Corp.
|
Apr 06, 2023 02:57PM
|
Re: short interest up 60% from 230,476 to 369,578/OTC/market
|
1
|
Resverlogix Corp.
|
Apr 27, 2023 12:16PM
|
Re: Some history
|
5
|
Resverlogix Corp.
|
Jan 25, 2023 01:01PM
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
6
|
Zenith Epigenetics
|
Oct 29, 2023 09:37PM
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
3
|
Zenith Epigenetics
|
Oct 28, 2023 11:44AM
|
Re: TNBC no longer active?
|
4
|
Zenith Epigenetics
|
Jun 29, 2023 11:24AM
|